Peter G. Linde - Publications

Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease.

Journal: Pediatric nephrology (Berlin, Germany)

Published: May 19, 2016

Overcoming Barriers in Kidney Health-Forging a Platform for Innovation.

Journal: Journal of the American Society of Nephrology : JASN

Published: April 30, 2016

Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: April 29, 2016

Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: November 04, 2014

Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.

Journal: Journal of cardiac failure

Published: April 14, 2014

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: October 31, 2013

Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.

Journal: American journal of nephrology

Published: March 30, 2013